BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2008
View Archived Issues
Preliminary study shows efficacy of aflibercept in diabetic macular edema
Read More
Phase II study data detail responses to tarenflurbil in mild Alzheimer's disease patients
Read More
Wyeth Pharmaceuticals terminates collaboration agreements with Solvay for bifeprunox
Read More
Pfizer receives approval for sustained-release Norvasc in Japan for hypertension and angina
Read More
GSK launches Imigran subcutaneous self-injection in Japan for migraine and cluster headache
Read More
Crucell enters vaccine development agreement with Wyeth
Read More
Data Safety Monitoring Board recommends continuation of HF-0220 phase II trial
Read More
LifeCycle reports positive top-line results for phase II LCP-Tacro trial
Read More
Paladin files new drug submission for Seasonique in Canada
Read More
Alexza's AZ-104 phase IIa trial meets primary endpoint
Read More
ALK-Abello announces positive third year results from Grazax trial
Read More
Array BioPharma reports positive phase II top-line results for ARRY-797
Read More
Novel agents for glaucoma disclosed in recent Pfizer patents
Read More
NeuroSearch reports positive and confirmatory results from TIPO-2 trial
Read More
Recent Organon and Activesite patents report novel antithrombotic agents
Read More
Novel therapeutic agents for respiratory disorders described in recent Boehringer Ingelheim patent
Read More
Reliable Abeta burden detection with Bayer's novel PET tracer
Read More
New beta3 adrenoceptor agonists may be useful in overactive bladder
Read More
Phase IIa multiple dose AVT-01 study shows safety but does not confirm efficacy
Read More
Results reported for phase II Juvista trial in scar revision and breast augmentation
Read More
FDA approves new dosage strengths of Endo's Opana
Read More
Pfizer to acquire Serenex and the rights to SNX-5422
Read More
Pharmacopeia initiates phase II clinical study of PS-433540 for hypertension
Read More
Data Safety Monitoring Board recommends continuation of Debio-9902 SR trial
Read More
GSK terminates development of Dacart in the treatment of malaria
Read More
MP-376 granted U.S. orphan drug status for the treatment of cystic fibrosis
Read More
Vermillion and Stanford University enter agreement for novel biomarker panel for PAD
Read More
CHMP recommends 300 mg tablet of sanofi-aventis and Bristol-Myers Squibb's Plavix
Read More
FDA grants fast track designation to Bioniche for Urocidin
Read More